Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISIL
1626
DELISTED
Intersil Corp
ISIL
| $3.09M | 0.01% |
264,205
+103,995
| +65% | +$1.16M |
|
1627
Quad
QUAD
$526M
| $3.09M | 0.01% |
255,165
-199,942
| -44% | -$3.03M |
|
1628
Valmont Industries
VMI
$9.13B
| $3.08M | 0.01% |
32,511
-16,949
| -34% | -$1.85M |
|
1629
Braskem
BAK
$650M
| $3.08M | 0.01% |
+365,542
| New | +$2.82M |
|
1630
Pembina Pipeline
PBA
$28B
| $3.08M | 0.01% |
+128,353
| New | +$3.59M |
|
|
CKP
1631
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $3.07M | 0.01% |
423,827
+226,071
| +114% | +$1.89M |
|
1632
Imperial Oil
IMO
$63.6B
| $3.07M | 0.01% |
+97,200
| New | +$3.37M |
|
1633
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.5B
| $3.06M | 0.01% |
62,909
+1,159
| +2% | +$56.4K |
|
1634
Korn Ferry
KFY
$4.33B
| $3.06M | 0.01% |
92,570
-383,141
| -81% | -$13.1M |
|
1635
Seres Therapeutics
MCRB
$50.2M
| $3.06M | 0.01% |
5,163
+1,016
| +24% | +$829K |
|
1636
World Acceptance Corp
WRLD
$902M
| $3.04M | 0.01% |
113,424
+90,516
| +395% | +$3.85M |
|
|
GBT
1637
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.04M | 0.01% |
+72,168
| New | +$3.4M |
|
1638
Telkom Indonesia
TLK
$15B
| $3.03M | 0.01% |
+170,174
| New | +$3.44M |
|
|
UNT
1639
DELISTED
UNIT Corporation
UNT
| $3.03M | 0.01% |
268,983
+91,620
| +52% | +$1.56M |
|
1640
Sabra Healthcare REIT
SBRA
$5.32B
| $3.02M | 0.01% |
130,234
+32,529
| +33% | +$830K |
|
|
TW
1641
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $3.01M | 0.01% |
25,676
+24,846
| +2,993% | +$3.08M |
|
1642
Titan International
TWI
$464M
| $3.01M | 0.01% |
455,311
+131,937
| +41% | +$1.15M |
|
1643
Toronto Dominion Bank
TD
$197B
| $2.99M | 0.01% |
75,955
-1,268,926
| -94% | -$50.5M |
|
1644
MGE Energy Inc
MGEE
$2.99B
| $2.99M | 0.01% |
+72,569
| New | +$2.87M |
|
1645
Vodafone
VOD
$37.3B
| $2.98M | 0.01% |
93,995
-187,415
| -67% | -$6.67M |
|
|
AZPN
1646
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.98M | 0.01% |
78,699
+69,099
| +720% | +$2.62M |
|
1647
Invesco Mortgage Capital
IVR
$801M
| $2.98M | 0.01% |
24,358
-39,606
| -62% | -$5.52M |
|
|
VXZ
1648
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $2.98M | 0.01% |
57,237
+3,888
| +7% | +$180K |
|
1649
Atlantic Union Bankshares
AUB
$5.79B
| $2.98M | 0.01% |
124,050
+71,767
| +137% | +$1.7M |
|
1650
Federal Realty Investment Trust
FRT
$10.2B
| $2.97M | 0.01% |
21,797
+6,691
| +44% | +$894K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.